Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure
Overview
Radiology
Affiliations
Objectives: This study sought to identify whether impaired global longitudinal strain (GLS), diastolic dysfunction (DD), or left atrial enlargement (LAE) should be added to stage B heart failure (SBHF) criteria in asymptomatic patients with type 2 diabetes mellitus.
Background: SBHF is a precursor to clinical heart failure (HF), and its recognition justifies initiation of cardioprotective therapy. However, original definitions of SBHF were based on LV hypertrophy and impaired ejection fraction.
Methods: Patients with asymptomatic type 2 diabetes mellitus ≥65 years of age (age 71 ± 4 years; 55% men) with preserved ejection fraction and no ischemic heart disease were recruited from a community-based population. All underwent a standard clinical evaluation, and a comprehensive echocardiogram, including assessment of left ventricular hypertrophy (LVH), LAE, DD (abnormal E/e'), and GLS (<16%). Over a median follow-up of 1.5 years (range 0.5 to 3), 20 patients were lost to follow-up, and 290 individuals were entered into the final analyses.
Results: In this asymptomatic group, LV dysfunction was identified in 30 (10%) by DD, 68 (23%) by LVH, 102 (35%) by LAE, and 68 (23%) by impaired GLS. New-onset HF developed in 45 patients and 4 died, giving an event rate of 112/1,000 person-years. Survival free of the composite endpoint (HF and death) was about 1.5-fold higher in patients without a normal, compared with an abnormal echocardiogram. LVH, LAE, and GLS <16% were associated with increased risk of the composite endpoint, independent of ARIC risk score and glycosylated hemoglobin, but abnormal E/e' was not. The addition of left atrial volume and GLS provided incremental value to the current standard of clinical risk (ARIC score) and LVH. In a competing-risks regression analysis, LVH (hazard ratio: 2.90; p < 0.001) and GLS <16% (hazard ratio: 2.26; p = 0.008), but not DD and LAE were associated with incident HF.
Conclusions: Subclinical left ventricular systolic dysfunction is prevalent in asymptomatic elderly patients with type 2 diabetes mellitus, and impaired GLS is independent and incremental to LVH in the prediction of incident HF.
Wang L, Liu S, Ke J, Cao B, Wang D, Zhao Q Diabetol Metab Syndr. 2025; 17(1):81.
PMID: 40050939 PMC: 11884144. DOI: 10.1186/s13098-025-01648-1.
Liu Y, Li N, Zhang S, Feng Y, Zhang Y, Shao Y Sci Rep. 2025; 15(1):6071.
PMID: 39972067 PMC: 11839949. DOI: 10.1038/s41598-025-90281-z.
Marwick T, Lam C, Liu Y, Del Prato S, Rosenstock J, Butler J Cardiovasc Diabetol. 2025; 24(1):16.
PMID: 39806375 PMC: 11730511. DOI: 10.1186/s12933-024-02554-y.
Myocardial Abnormalities Across the AHA/ACC Stages of Heart Failure in Patients With Diabetes.
Yang W, Zhu L, Wu W, Jiang M, Zhang H, Zhou D JACC Asia. 2025; 4(12):940-952.
PMID: 39803000 PMC: 11712003. DOI: 10.1016/j.jacasi.2024.08.016.
Dattani A, Yeo J, Brady E, Cowley A, Marsh A, Sian M J Cardiovasc Magn Reson. 2024; 26(2):101120.
PMID: 39477154 PMC: 11663768. DOI: 10.1016/j.jocmr.2024.101120.